Oral Nutritional Supplementation in Children at Risk of Undernutrition

Exclusion Criteria

• •Child has a height-for-age z-score ≥ 0.
• •Child is currently drinking an oral nutritional supplement (ONS) on a regular basis (≥ 15 days in the past month)
• •Child is participating in another study that has not been approved as a concomitant study by AN.
• •Child has been diagnosed with the following:
• •* Galactosemia, or an allergy or intolerance to any ingredient found in the study product
• •* Acute or chronic infections including but not restricted to respiratory infections, diarrhea, Hepatitis B or C, HIV infection or tuberculosis
• •* Severe gastrointestinal disorders such as celiac disease, short bowel syndrome, pancreatic insufficiency, or cystic fibrosis
• •* Neoplastic, renal, hepatic or cardiovascular, hormonal or metabolic disorders, Down's syndrome or significant, uncorrected cardiac anomalies that may impact growth
• •* Infantile anorexia nervosa, developmental disability, including physical disorders such as cerebral palsy, or a developmental delay that is considered too severe for participation
• •* Disorders of hemoglobin structure, function or synthesis
• •* Clinically significant nutritional deficiency requiring specialty nutritional therapy
• •* Any other clinically significant medical condition, which in the investigator's opinion, makes him or her unsuitable for inclusion in the study.